OMRON Healthcare Co., Ltd. has revealed further investment in the India-focused AI medtech startup TRICOG HEALTH INDIA PRIVATE LIMITED
Following the historic approval granted in August 2025 by India’s Central Drugs Standard Control Organization (CDSCO), Shilpa Medicare has launched NODUCA (Nor Ursodeoxycholic Acid, or norUDCA), the first medication of its kind to be introduced in
.png "Sanofi's Teizeild Gains EU Backing for Type 1 Diabetes Breakthrough")
Sanofi’s type?1 diabetes therapy Teizeild (teplizumab) has been recommended for approval by the European Medicines Agency’s Committee for Medicinal Products for Human Use. This makes Teizeild the first disease-modifying therapy to type 1 diabetes...
.png "Zydus Secures USFDA Nod for Leuprolide Acetate Injection")
Zydus Lifesciences receives final USFDA approval for its Leuprolide Acetate injection, the generic version of Lupron, used in the palliative treatment of advanced prostate cancer. The approval strengthens Zydus’s oncology portfolio in the US market.
.png "Alembic Pharmaceuticals Secures USFDA Nod for Diltiazem Tablets")
Alembic Pharmaceuticals today received its final USFDA clearance of its ANDA of Diltiazem Hydrochloride Tablets 30mg, 60mg, 90mg, and 120mg. This is a strategic victory that strengthens the position of the U.S. generics market of Alembic...
.png "Pfizer Completes Metsera Deal to Expand Obesity Drug Pipeline")
Pfizer acquisition news took center stage today as the company confirmed it has closed its purchase of Metsera, a clinical-stage biotech pushing new treatments for obesity and cardiometabolic disease. The move marks a major step for Pfizer as it...
Zydus Lifesciences has secured final approval from the United States Food and Drug Administration (USFDA) for its Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial, the generic equivalent of Lupron Injection (1 mg/0.2 mL)
Merck is reportedly nearing an agreement to acquire Cidara Therapeutics, in a deal that would value the biotechnology firm above its current $3.3 billion market capitalization
Sun Pharmaceutical Industries Limited (Sun Pharma), India’s leading pharmaceutical company by revenue and prescriptions, has rolled out the #SeeBeyondSugar campaign — a national initiative aimed at boosting awareness and education around diabetic
.png "Abbott Unveils New Ensure Diabetes Care Formula in India")
Abbott has introduced an improved brand of its India Diabetes Care form of the brand, Sure, focusing on science-based nutrition to individuals with diabetes. Today, the launch was announced, and is based on the results of more than 30 years of...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")